MedPath

To compare the effects of two different groups of drugs on gastric motility

Phase 4
Conditions
Health Condition 1: -
Registration Number
CTRI/2023/11/059949
Lead Sponsor
Dr Deekshanth Ramakrishnan
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1)Patients belonging to ASA physical status I and II

2)Age 18-60 years, belonging to either gender

3)Patients giving informed written and valid consent

4)Patients undergoing upper/lower ureteric and urethral procedures under spinal anaesthesia

Exclusion Criteria

1)Patients with diabetes mellitus, chronic renal failure

2)Pregnant females

3)Patients on any drugs causing a delay in gastric emptying like aluminum hydroxide, antacids, calcium channel blockers, diphenhydramine, L-Dopa, lithium and tricyclic antidepressants(TCAs)

•Patients on pantoprazole and metaclopramide

•Patients having hypersensitivity to any of the study drugs

•Patients with prior history of gastrointestinal disease and gastrointestinal reflux disease

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To detect opioid-induced delay in gastric emptying in the perioperative periodTimepoint: Gastric residual volume will be measured before induction of anaesthesia, immediately after surgery, 2 hours postoperative, 6 hours postoperative
Secondary Outcome Measures
NameTimeMethod
1)To find the efficacy of gastric ultrasound as a bedside tool for assessing the quality & quantity of gastric contents in the peri-operative period. <br/ ><br>2)To assess the delay in gastric emptying produced by ketamine. <br/ ><br>3)To find out if pain produces delay in gastric emptying. <br/ ><br>Timepoint: Gastric residual volume will be measured just be induction of anaesthesia, immediately after surgery, 2hours postoperative, 6hours postoperative
© Copyright 2025. All Rights Reserved by MedPath